Linda Spiegelberg

Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials

Linda Spiegelberg, Ruud Houben, Raymon Niemans et al. · Clinical and Translational Radiation Oncology · 2019 · 115 citations · Full text

Medicine, Oncology, Pharmacology +16

Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity

Linda Spiegelberg, Stefan J. van Hoof, Rianne Biemans et al. · Radiotherapy and Oncology · 2019 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17

An orthotopic non-small cell lung cancer model for image-guided small animal radiotherapy platforms

Venus Sosa Iglesias, Stefan J. van Hoof, Ana Vaniqui et al. · British Journal of Radiology · 2018 · 23 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Gene Expression Analysis Reveals Inhibition of Radiation-Induced TGFβ-Signaling by Hyperbaric Oxygen Therapy in Mouse Salivary Glands

Linda Spiegelberg, Sigrid Swagemakers, Wilfred F. J. van IJcken et al. · Molecular Medicine · 2014 · 22 citations · Full text

Dentistry, Molecular Biology, Oncology +17

Hyperbaric Oxygen Treatment of Tissue-Engineered Mucosa Enhances Secretion of Angiogenic Factors <i>In Vitro</i>

W. Tra, Linda Spiegelberg, Bastiaan Tuk et al. · Tissue Engineering Part A · 2013 · 16 citations

Engineering, Bioengineering, Biomedical Engineering +12